Planagumà A, Domènech T, Pont M, Calama E, García-González V, López R, Aulí M, López M, Fonquerna S, Ramos I, de Alba J, Nueda A, Prats N, Segarra V, Miralpeix M, Lehner MD (October 2015). “Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation”. 《Pulmonary Pharmacology & Therapeutics》 34: 37–45. doi:10.1016/j.pupt.2015.08.002. PMID26271598.
Rana AK, Li Y, Dang Q, Yang F (December 2018). “Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis”. 《International Immunopharmacology》 65: 348–359. doi:10.1016/j.intimp.2018.10.016. PMID30366278. S2CID53116963.
Planagumà A, Domènech T, Pont M, Calama E, García-González V, López R, Aulí M, López M, Fonquerna S, Ramos I, de Alba J, Nueda A, Prats N, Segarra V, Miralpeix M, Lehner MD (October 2015). “Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation”. 《Pulmonary Pharmacology & Therapeutics》 34: 37–45. doi:10.1016/j.pupt.2015.08.002. PMID26271598.
Rana AK, Li Y, Dang Q, Yang F (December 2018). “Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis”. 《International Immunopharmacology》 65: 348–359. doi:10.1016/j.intimp.2018.10.016. PMID30366278. S2CID53116963.
Rana AK, Li Y, Dang Q, Yang F (December 2018). “Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis”. 《International Immunopharmacology》 65: 348–359. doi:10.1016/j.intimp.2018.10.016. PMID30366278. S2CID53116963.